Onconova Therapeutics's total assets for Q3 2023 were $27.04M, a decrease of -11.26% from the previous quarter. ONTX total liabilities were $12.52M for the fiscal quarter, a 8.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.